Evidence map›Paper›PMID 26407674›Full record

ArticleSystematic reviews2015

Rapid Review Summit: an overview and initiation of a research agenda.

Julie Polisena, Chantelle Garritty, Craig A Umscheid, Chris Kamel, Kevin Samra, Jeannette Smith, Ann Vosilla

Abstract readConference Proceedings
In one paragraph

Article in Systematic reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Home Health and Community Care Workers' Occupational Exposure to Secondhand Smoke: A Rapid Literature Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Review
  7. Article
  8. Optimal literature search for systematic reviews in surgery.Langenbeck's archives of surgery · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julie PolisenaCanadian Agency for Drugs and Technologies in Health (CADTH), 600-865 Carling Ave., Ottawa, ON, K1S 5S8, Canada. Juliep@cadth.ca.
Chantelle GarrittyKnowledge Synthesis Group, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada. cgarritty@ohri.ca.
Craig A UmscheidECRI Institute - Penn Medicine AHRQ EPC and the Center for Evidence-Based Practice and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. craig.umscheid@uphs.upenn.edu.
Chris KamelCanadian Agency for Drugs and Technologies in Health (CADTH), 600-865 Carling Ave., Ottawa, ON, K1S 5S8, Canada. chrisk@cadth.ca.
Kevin SamraStrategic Projects Branch, BC Ministry of Health, 5th floor, 1483 Douglas Street, PO BOX 9634 STN PROV GOVT, Victoria, British Columbia, Canada. kevin.samra@gov.bc.ca.
Jeannette SmithCanadian Agency for Drugs and Technologies in Health (CADTH), 600-865 Carling Ave., Ottawa, ON, K1S 5S8, Canada. jeannettes@cadth.ca.
Ann VosillaCanadian Agency for Drugs and Technologies in Health (CADTH), 600-865 Carling Ave., Ottawa, ON, K1S 5S8, Canada. annv@cadth.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demand for accelerated forms of evidence synthesis is on the rise, largely in response to requests by health care decision makers for expeditious assessment and up-to-date information about health care technologies and health services and programs. As a field, rapid review evidence synthesis is marked by a tension between the strategic priority to inform health care decision-making and the scientific imperative to produce robust, high-quality research that soundly supports health policy and practice. In early 2015, the Canadian Agency for Drugs and Technologies in Health convened a forum in partnership with the British Columbia Ministry of Health, the British Columbia Centre for Clinical Epidemiology and Evaluation, the Ottawa Hospital Research Institute, and the University of Pennsylvania. More than 150 evidence synthesis producers and end users attended the Rapid Review Summit: Then, Now and in the Future. The Summit program focused on the evolving role and practices of rapid reviews to support informed health care policy and clinical decision-making, including the uptake and use of health technology assessment. Our discussion paper highlights the important discussions that occurred during the Rapid Review Summit. It focuses on the initial development of a research agenda that resulted from the Summit presentations and discussions. The research topics centered on three key areas of interest: (1) how to conduct a rapid review; (2) investigating the validity and utility of rapid reviews; and (3) how to improve access to rapid reviews.

Indexed as

Biomedical ResearchDelivery of Health CareEvidence-Based MedicineHealth PolicyReview Literature as TopicTechnology Assessment, BiomedicalAccess to InformationCanadaHumansResearch Design

Identifiers

PMID26407674
PMCPMC4583747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.